Abl Diagnostics (ABLD) | Stock Overview & Key Data
Abl Diagnostics Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €76.00 on October 31, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Sep 30, 2022
Annual Income Flow
2024
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Abl Diagnostics
ABLD
|
44.38M Small-cap | -2.29% | 44.92% | -0.58% | 11.76% | -10.94% | -37.25% | -41.03% | 51.33% | 95.43% | 36.80% | 36.80% |
|
Equasens
EQS
|
589.23M Mid-cap | -2.47% | 0.54% | 10.13% | -9.42% | -16.39% | -20.51% | -51.36% | -56.42% | 60.55% | 266.39% | 266.39% |
|
Cegedim S.A
CGM
|
188.10M Mid-cap | -3.20% | -0.17% | 1.15% | 1.15% | 1.15% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% | 6.91% |
|
Smaio S.A
ALSMA
|
47.02M Small-cap | 1.63% | 12.95% | 27.30% | 31.13% | 41.79% | 128.87% | 219.42% | 65.36% | 65.36% | 65.36% | 65.36% |
|
Intrasense S.A
ALINS
|
11.80M Small-cap | 0.00% | 4.55% | -4.17% | -11.54% | 0.00% | -25.00% | -45.45% | -68.42% | -73.91% | -95.75% | -95.75% |
|
Media Lab S.p.A
MLLAB
|
8.06M Small-cap | 0.00% | -0.59% | 1.20% | 9.03% | -5.59% | 53.64% | 152.24% | 95.38% | -1.46% | -1.46% | -1.46% |
Ownership & Short Interest
Calculate Your Abl Diagnostics Investment Returns
Long-Term Investment Performance Analysis
Abl Diagnostics stock price in Apr 2016 was €1.91, A €1,000.00 lump sum investment in Abl Diagnostics made 9 years ago would be worth approximately €2,345.55 today, representing a strong return of 134.55%. This translates to an annualized return (CAGR) of 9.41%.
9 Years 5 Months Investment Scenario (Apr 2016 - Oct 2025)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ABLD's 52-week high and low?
- In the last 52 weeks, Abl Diagnostics reached a high of €8.10 (on March 6, 2025) and a low of €2.40 (on December 23, 2024).
- What is the market cap and P/E ratio for ABLD?
- Curious about Abl Diagnostics's size and valuation? Its market capitalization stands at 44.38M. When it comes to valuation, the P/E ratio (trailing twelve months) is 92.00, and the forward P/E (looking ahead) is 46.00.
- Does ABLD pay dividends? If so, what's the yield?
- Yes, Abl Diagnostics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.92%, and the company has paid an average of €0.11 per share annually over the past 3 years.
- Who are Abl Diagnostics's main competitors or similar companies to consider before investing?
When looking at Abl Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS589.23M Healthcare Health Information Services -20.51% -51.36% Cegedim S.A
CGM188.10M Healthcare Health Information Services 6.91% 6.91% Smaio S.A
ALSMA47.02M Healthcare Health Information Services 128.87% 219.42% Intrasense S.A
ALINS11.80M Healthcare Health Information Services -25.00% -45.45% Media Lab S.p.A
MLLAB8.06M Healthcare Health Information Services 53.64% 152.24% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abl Diagnostics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Abl Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.73%, the Debt to Equity ratio from the most recent quarter is 38.66, and its Gross Profit Margin stands at 61.04%.
- What is the recent revenue and earnings growth for ABLD?
- Looking at Abl Diagnostics's growth, its revenue over the trailing twelve months (TTM) was €6M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.40%, and quarterly earnings saw a YoY growth of 161.30%.
- How much of ABLD stock is held by insiders and institutions?
- Wondering who owns Abl Diagnostics stock? Company insiders (like executives and directors) hold about 99.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.